Abstract
The use of the versatile N-heterocyclic carbene (NHC) gold(I) hydroxide [Au(OH)(IPr)] (IPr = N,N '-bis(2,6-diisopropylpheny)imidazol-2-ylidene) as precursor permits the expedient synthesis of a series of cationic heteroleptic [Au(NHC)(NHC')](+) and [Au(NHC)(PR3)](+) complexes by proton. lysis with the appropriate acid salts. Complete characterization by H-1 and C-13 NMR spectroscopy and by single-crystal X-ray diffraction was performed in order to discern electronic and structural differences between cationic heteroleptic [Au(NHC)(NHC')](+) and [Au(NHC)(PR3)](+) congeners.
Original language | English |
---|---|
Pages (from-to) | 5402-5408 |
Number of pages | 7 |
Journal | Organometallics |
Volume | 29 |
Issue number | 21 |
DOIs | |
Publication status | Published - 8 Nov 2010 |
Keywords
- GOLD(I) COMPLEXES
- ANTICANCER AGENT
- METAL-COMPLEXES
- PHASE-I
- CYTOTOXICITY
- DERIVATIVES
- LIGANDS
- BEARING